S

Salarius Pharmaceuticals

D
SLRX
USD
-0.08
(-5.2288%)
Market Closed
231.000
Volume
-214.48
EPS
-
Div Yield
-0.166094
P/E
2,089,677.65
Market Cap
Today
-5.2288%
1 Week
-11.043%
1 Month
-1.361%
6 Months
-62.404%
12 Months
-77.637%
Year To Date
-71.899%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
O
OPK
0.08
(5.5172%)
USD
MRK
MRK
1.5
(1.4825%)
USD
P
PSTV
-0.07
(-4.8951%)
USD
ABBV
ABBV
0.37
(0.1846%)
USD
GSK
GSK
-0.41
(-1.1184%)
USD
B
BHC
-0.145
(-1.5376%)
USD
Z
ZYME
0.09
(0.5376%)
USD
BMY
BMY
-0.52
(-0.9506%)
USD
JNJ
JNJ
-0.65
(-0.4147%)
USD
PFE
PFE
-0.59
(-2.149%)
USD

Title:
Salarius Pharmaceuticals Inc.

Sector:
Healthcare
Industry:
Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Do you need help or have a question?
Contact Us